Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of LAI MMV055 Alone and in Combination With MMV371 in Healthy Participants
Abroad (travel likely)RecruitingPHASE1
Conditions
Malaria, Falciparum
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Quotient Sciences, Nottingham, United Kingdom
Contact: Study coordinator (Peter Green, Project Manager) · peter.green@quotientsciences.com · +44 (0)115 974 9000Contact: Principal Investigator (Nand Singh, BSc, MD, DPM, FFPM)
Study leads
Project Director, PhD
Study Director
MMV